Antidote: FDA took wrong stance on Provenge for prostate cancer
Marc Siegel, MD
April 15 2009
I haven't covered prostate cancer in this space before, in part because the choices, though controversial, have been somewhat static ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.